The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Antibody-Dependent Enhancement
Hierarchy: | ∟ ∟ ∟ ∟ ∟ Antibody-Dependent Enhancement 41 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Antibody-Dependent Enhancement 41 coordinate concepts∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ |
Broader terms: | |
Annotation: | enhancement of viral infectivity: read MeSH definition
X |
historyNote*: | 96
X |
publicMeSHNote*: | 96
X |
Scope note: | Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by Fc receptors (RECEPTORS, FC) or by complement receptors (RECEPTORS, COMPLEMENT). Either the virus is complexed with antiviral IMMUNOGLOBULIN G and binds to Fc receptors, or virus is coated with antiviral IMMUNOGLOBULIN M and binds to complement receptors.
X |
activeMeSHYear*: | |
dateCreated*: | 1995-05-26X |
dateEstablished*: | 1996-01-01X |
dateRevised*: | 2001-08-07X |
recordAuthorizer*: | sjnX |
recordMaintainer*: | sjnX |
recordOriginator*: | AGSX |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Vasta-aineriippuvainen voimistaminen (fi) XAcrecentamiento Dependiente de Anticuerpo (es) Antikörperabhängige Verstärkung (de) zvýšená infektivita v přítomnosti protilátek (cs) |
Share: |
Loading results...